Cargando…

Molecular design for recombinant adeno-associated virus (rAAV) vector production

Recombinant adeno-associated virus (rAAV) vectors are increasingly popular tools for gene therapy applications. Their non-pathogenic status, low inflammatory potential, availability of viral serotypes with different tissue tropisms, and prospective long-lasting gene expression are important attribut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aponte-Ubillus, Juan Jose, Barajas, Daniel, Peltier, Joseph, Bardliving, Cameron, Shamlou, Parviz, Gold, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778157/ https://www.ncbi.nlm.nih.gov/pubmed/29204900 http://dx.doi.org/10.1007/s00253-017-8670-1

Ejemplares similares

Proteome profiling and vector yield optimization in a recombinant adeno‐associated virus‐producing yeast model
por: Aponte‐Ubillus, Juan Jose, et al.
Publicado: (2020)

Generation of infectious recombinant Adeno-associated virus in Saccharomyces cerevisiae
por: Barajas, Daniel, et al.
Publicado: (2017)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
por: Cole, Liam, et al.
Publicado: (2021)

Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
por: Buck, Thilo M., et al.
Publicado: (2020)

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
por: Hagen, Sven, et al.
Publicado: (2014)

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
por: Bauer, Amelie, et al.
Publicado: (2022)

The recombinant adeno-associated virus vector (rAAV2)-mediated apolipoprotein B mRNA-specific hammerhead ribozyme: a self-complementary AAV2 vector improves the gene expression
por: Zhong, Shumei, et al.
Publicado: (2004)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Ultracentrifugation-free chromatography-mediated large-scale purification of recombinant adeno-associated virus serotype 1 (rAAV1)
por: Tomono, Taro, et al.
Publicado: (2016)

Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes In vitro and In vivo
por: Schober, Alexandra L., et al.
Publicado: (2016)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
por: Tkatch, Tatiana, et al.
Publicado: (2022)

Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery
por: Towne, Chris, et al.
Publicado: (2009)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
por: Li, Rilun, et al.
Publicado: (2013)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
por: Derkaev, Artem A., et al.
Publicado: (2022)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice
por: Mulcrone, Patrick L., et al.
Publicado: (2022)

High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector
por: Weger, Stefan
Publicado: (2022)

Improving retinal vascular endothelial cell tropism through rational rAAV capsid design
por: Periasamy, Ramesh, et al.
Publicado: (2023)

Computational fluid dynamic modeling of alternating tangential flow filtration for perfusion cell culture
por: Radoniqi, Flaka, et al.
Publicado: (2018)

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Development of human gene reporter cell lines using rAAV mediated homologous recombination
por: Fernandez, Sandra L., et al.
Publicado: (2007)

Simple and precise targeted editing of the human genome using rAAV-mediated homologous recombination
por: Torrance, Christopher J
Publicado: (2012)

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
por: Esmagambetov, Ilias B., et al.
Publicado: (2023)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Subcellular distribution of the rAAV genome depends on genome structure
por: Oh, Nuri, et al.
Publicado: (2023)

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities
por: Rumachik, Neil G., et al.
Publicado: (2021)

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
por: Arnett, Andrea L. H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8nrhhitie2bt85m8bin41irmul